BLSM 10-Q: SEC filing
BlossomHill Therapeutics
Filed with the SEC on · accession 0001193125-26-458561
BLSM filed a 10-Q (quarterly report) with the SEC on Nov 12, 2026. BlossomHill Therapeutics filed its Q3 2026 Form 10-Q, reporting quarterly financial results and disclosing its August 2026 IPO. The stock moved -7.9% by the first close after the filing.
Summary of the filing
BlossomHill Therapeutics filed its Q3 2026 Form 10-Q, reporting quarterly financial results and disclosing its August 2026 IPO. The filing includes standard financial statements, equity plan details, and related-party disclosures.
Key details
How BLSM stock reacted
Close before
$16.12
Nov 11, 2026
First close after
-7.94%
$14.84
5 trading days
—
Since filing
—
✦ Ask GOAX AI about this filing — what it means for BLSM, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for BLSM?
Click hereFrequently asked questions
What did BLSM file with the SEC on Nov 12, 2026?
BLSM filed a 10-Q (SEC filing). BlossomHill Therapeutics filed its Q3 2026 Form 10-Q, reporting quarterly financial results and disclosing its August 2026 IPO. The filing includes standard financial statements, equity plan details, and related-party disclosures.
How do I read a 10-Q?
The quarterly report: unaudited results for the quarter plus management’s comments. Compare revenue, margins and cash flow with the same quarter last year. Check MD&A for guidance changes and what drove the quarter.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 10-Q (quarterly report): The quarterly report: unaudited results for the quarter plus management’s comments.
How did BLSM stock react to this filing?
BLSM closed at $16.12 before the filing and $14.84 on Nov 12, 2026 (-7.94%).
Other BLSM SEC filings
Get alerts when BLSM files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days